Innovating smarter and kinder medicines
Welcome to ChemKAS Pharmaceutics
ChemKAS Pharmaceutics is focused on developing a broad range of new targeted molecules to clinical use for the treatment and diagnosis of cancer and other diseases with unmet need.
Utilising our exceptional capabilities in medicinal chemistry including radiopharmaceuticals, preclinical and translational science, we have an attractive portfolio of assets including molecules for unique cancer targeting and for molecular imaging or molecular targeted radiotherapy.
Using our broad technological capabilities and commitment to partnering, we are able to develop novel therapies or diagnostic agents rapidly.
Our priority is to develop effective therapies with standard-of-care to treat aggressive and resistance cancers.
Disrupt cancer/disease progression
Kill targeted cancer cells by incorporation of a radionuclide
Act as a whole body imaging agent
for diagnostic purposes and non-invasive patient therapy response monitoring.
